GE Healthcare will license some technology from Insight Genetics to develop a molecular diagnostic test that detects mutations in the ALK gene, an indicator of lung and other cancers.
A newly formed contract research organization in California is hoping to set itself apart from competitors by focusing the bulk of its work on combating pediatric and orphan diseases.
Bionor's latest HIV vaccine, Vacc-C5, is ready to go into therapeutic clinical trials at Oslo University Hospital.
Researchers at the Oregon National Primate Research Center have published a new method in Nature Medicine that could make vaccines even safer, and more effective as well.
Phase II results of Immune Network's therapeutic tuberculosis vaccine were presented at the Drug Resistance and Persistence in Tuberculosis meeting in Uganda, part of the Keystone Symposia Global Health Series.
A team of engineers at MIT has developed a jet delivery technology that shoots the vaccine (or therapeutic) through the skin and is less painful than a needle.
The New Jersey CRO has teamed up with Bayer Healthcare in a deal that will see the two helping one another with R&D services.
Lundbeck is touting mid-stage data underscoring the effectiveness of its experimental Alzheimer's drug Lu AE58054 for improving cognition and the quality of life for patients.
Investigators from the Dana-Farber Cancer Institute will join forces with France's Institut Gustave Roussy and others to work on the translational effort.
BMS has high hopes for making BMS-936558 the latest pearl to add to its string of ASCO jewels.